MAPT and Alzheimer disease: These biomarkers allow for the identification of those at risk or who are just beginning to develop the disease, and they also offer important insights into the underlying pathological processes [25]. The proteins tau and beta-amyloid are important indicators linked to Alzheimer's disease.